# The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

> **NCT03860220** · PHASE4 · COMPLETED · sponsor: **Hyo-Soo Kim** · enrollment: 252 (actual)

## Conditions studied

- Hypertension
- Dyslipidemias

## Interventions

- **DRUG:** NEWSTATIN TS
- **DRUG:** CADUET

## Key facts

- **NCT ID:** NCT03860220
- **Lead sponsor:** Hyo-Soo Kim
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-25
- **Primary completion:** 2023-09-07
- **Final completion:** 2023-09-07
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03860220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03860220, "The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03860220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*